Our Services
Medical Information
Helpful Resources
Published on: 4/28/2026
Metformin does not directly damage the kidneys and can be safely continued down to an eGFR of 30 mL/min/1.73 m² with appropriate dose adjustments, preserving its benefits in blood sugar control and weight management while keeping the already rare risk of lactic acidosis extremely low. Routine monitoring of eGFR and creatinine, along with vigilance for risk factors like dehydration or iodinated contrast studies, helps ensure safe use.
There are several factors to consider. See below for more important details that could impact your next steps in managing diabetes and kidney health.
Metformin is one of the most commonly prescribed medications for type 2 diabetes. Despite decades of use, myths persist about metformin and kidney damage. In this article, we'll separate fact from fiction, review current guidelines, and offer clear advice on what you can do if you're taking metformin.
Metformin works by:
These benefits, combined with a low risk of low blood sugar (hypoglycemia), make metformin a first-line therapy in type 2 diabetes.
Your kidneys filter waste and extra fluid from the blood, maintain electrolyte balance, and regulate blood pressure. Kidney function is typically measured by:
As kidney function declines, the body clears drugs more slowly. That's where concerns about metformin and kidney damage come in.
Reality: There's no strong evidence that metformin itself causes structural damage to the kidneys. Studies dating back decades have not linked metformin to progressive kidney injury.
Reality: Lactic acidosis—build-up of lactic acid in the blood—is extremely rare in metformin users. The risk rises only when kidney function is severely impaired, because metformin is cleared by the kidneys.
Professional societies and regulatory agencies have updated their recommendations in recent years:
(Source: American Diabetes Association, European Association for the Study of Diabetes, and FDA updates.)
Following these cut-offs helps to:
In many cases, stopping metformin prematurely can lead to worsening blood sugar control and weight gain.
While very uncommon, lactic acidosis risk increases with:
If any of these occur, temporary discontinuation of metformin can be considered, with close follow-up and re-assessment of kidney function.
If you're on metformin, it's wise to have routine checks:
Early detection of worsening kidney function helps you and your healthcare team adjust metformin doses safely.
Chronic Kidney Disease (CKD) can be quiet in the early stages. Symptoms may appear only when kidney damage is moderate to advanced. Watch for:
If you notice any of these warning signs and want to better understand your risk, you can use a free Chronic Kidney Disease symptom checker to help determine whether further medical evaluation may be needed.
For most people with type 2 diabetes and mild to moderate kidney impairment, the benefits of metformin—better blood sugar control, potential cardiovascular protection, and weight neutrality—outweigh the very low risk of lactic acidosis when used appropriately.
This overview is meant to inform and empower you, not replace personalized medical advice. If you have any worries—especially about serious or life-threatening symptoms—please speak to a doctor right away. They can help you weigh the benefits and risks of metformin based on your individual health status.
(References)
* Inzucchi SE, Umpierrez GE, Gianchandani R, et al. Metformin in patients with chronic kidney disease: Updated recommendations. Ann Transl Med. 2018 Dec;6(Suppl 2):S16. doi: 10.21037/atm.2018.12.24. PMID: 30677569; PMCID: PMC6323674.
* Lazo-Langner A, Hanley G. Metformin use for diabetes in patients with chronic kidney disease. CMAJ. 2021 Jul 26;193(30):E1171-E1172. doi: 10.1503/cmaj.20210210. PMID: 34293883; PMCID: PMC8350171.
* Scheen AJ, Paquot N. Metformin and chronic kidney disease: New guidelines. Rev Med Liege. 2017 Nov;72(11):541-546. PMID: 29329744.
* Bell S, Di Tanna GL, Ceesay J, et al. Safe Use of Metformin in Chronic Kidney Disease: An Update. Diabetes Ther. 2021 Feb;12(2):373-388. doi: 10.1007/s13300-020-00977-1. Epub 2021 Jan 9. PMID: 33420822; PMCID: PMC7854611.
* Lupsa BC, Inzucchi SE. Metformin and Chronic Kidney Disease: Friend or Foe? Endocrinol Metab Clin North Am. 2018 Dec;47(4):729-743. doi: 10.1016/j.ecl.2018.06.002. Epub 2018 Aug 22. PMID: 30349890.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.